Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Fragment Based Lead Discovery

Andrew Hopkins's Biography

Andrew Hopkins, Professor, University of Dundee

Professor Hopkins is Chair of Medicinal Informatics in the College of Life Sciences, University of Dundee, where he is also the SULSA (Scottish Universities Life Sciences Alliance) Research Professor of Translational Biology and Director of SULSA. The Hopkins Laboratory is focused on developing new informatics and experimental methods for drug discovery, and applying these to the discovery and optimisation of novel leads. His research focuses on developing novel computational methods to automate lead optimisation and target identification, with a particular interest in the multi-target drug design. Experimentally, his lab is interested in advancing biosensor based screening, with particular interesting in developing fragment-based drug discovery for GPCRs. In 1993 Prof. Hopkins won a British Steel scholarship to attend University of Manchester graduating with a First Class Honours in Chemistry. Following a spell in the steel industry, Professor Hopkins undertook a doctorate in Molecular Biophysics under at the University of Oxford. Directly from Oxford he joined Pfizer, in 1998, where he established various new functions for the company including the Target Analysis Group, Indications Discovery and Knowledge Discovery. Prof Hopkins is a Fellow of the both the Royal Society of Chemistry and the Society of Biology. He has won several awards including the Royal Society of Chemistry’s Capps Green Zomaya medal (2008); Corwin Hansch Award (2007); Pfizer Team Achievement Award (2004); Pfizer Achievement Award (2002); Pfizer Leadership Award (2002). He has over 50 scientific publications and patents, including ten papers with over 100 citations. Prof Hopkins is the co-founder of Kinetic Discovery Ltd, a company offering biosensor-screening services to the pharmaceutical industry.

Andrew Hopkins Image

Emerging Applications of SPR Fragment Screening

Wednesday, 14 March 2012 at 14:45

Add to Calendar ▼2012-03-14 14:45:002012-03-14 15:45:00Europe/LondonEmerging Applications of SPR Fragment Screening

SPR is emerging as a primary screening methodology for fragment-based drug discovery. Here we discuss recent applications including advances in GPCR fragment screening.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonFragment Based Lead